Stryker impresses at first US MCAC (Medicare Coverage Advisory Committee) non-union fractures panel
This article was originally published in Clinica
Executive Summary
Stryker's orthobiologic product, OP-1, fared better than Medtronic's Infuse bone graft in a series of votes last week during a private sector advisory group assembled by Medicare to discuss coverage issues.